The US has a love-hate relationship with the Indian generics industry

Last week, reports claimed that Sun Pharma, an Indian generics manufacturer, was in talks to acquire Meda AB, a Swedish pharmaceutical company for $5 billion. This week saw Meda AB denying the rumour of a takeover. If there have been discussions,…

Get unlimited access to all IAM content